Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.6500
-0.0240 (-3.56%)
At close: Sep 9, 2025, 4:00 PM
0.6500
0.00 (0.00%)
After-hours: Sep 9, 2025, 7:43 PM EDT
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $4.32 million as of September 9, 2025. Its market cap has decreased by -45.31% in one year.
Market Cap
4.32M
Enterprise Value
1.40M
1-Year Change
-45.31%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $4.32M, a decrease of -93.65%. That is a compound annual growth rate of -23.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1.80M | -85.00% |
| Dec 31, 2024 | 12.00M | 118.18% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.22% |
| Dec 30, 2016 | 32.40M | -37.33% |
| Dec 31, 2015 | 51.70M | -23.97% |
| Jul 13, 2015 | 68.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |